Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,821Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Knight Therapeutics Inc

02 1Pediapharm Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Ciprofloxacin Hydrochloride, Fluocinolone Acetonide

Brand Name : OTIXAL

Patent Number : 2790652

Filing Date : 2011-02-28

Strength per Unit : 0.3% / 0.025% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OTIC

Patent Expiration Date : 2031-02-28

Date Granted : 2016-11-08

blank

02

Knight Therapeutics Inc

arrow
Peptide Process CMC
Not Confirmed

Knight Therapeutics Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Fluocinolone Acetonide

Brand Name : ILUVIEN

Patent Number : 2367092

Filing Date : 2000-03-22

Strength per Unit : 0.19 mg

Dosage Form : IMPLANT

Human Or VET : Human

Route of Administration : INTRAVITREAL

Patent Expiration Date : 2020-03-22

Date Granted : 2007-07-10

blank

03

Knight Therapeutics Inc

arrow
Peptide Process CMC
Not Confirmed

Knight Therapeutics Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Fluocinolone Acetonide

Brand Name : ILUVIEN

Patent Number : 2406277

Filing Date : 2001-04-19

Strength per Unit : 0.19 mg

Dosage Form : IMPLANT

Human Or VET : Human

Route of Administration : INTRAVITREAL

Patent Expiration Date : 2021-04-19

Date Granted : 2013-06-11

blank

04

Knight Therapeutics Inc

arrow
Peptide Process CMC
Not Confirmed

Knight Therapeutics Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Fluocinolone Acetonide

Brand Name : ILUVIEN

Patent Number : 2545650

Filing Date : 2004-10-26

Strength per Unit : 0.19 mg

Dosage Form : IMPLANT

Human Or VET : Human

Route of Administration : INTRAVITREAL

Patent Expiration Date : 2024-10-26

Date Granted : 2015-08-18

blank